Medical Properties Trust Navigates Tenant Strains Amid Heavy Debt Wall
Markets Daniel Marsh

Medical Properties Trust Navigates Tenant Strains Amid Heavy Debt Wall

Medical Properties Trust closed at $5.23, up 0.58%, as hospitals in its portfolio exhibit financial difficulties. The company confronts $2.83 billion in debt coming due over the next three years.

Rolls-Royce Surges on Nuclear Deal, Buyback & Dividend Focus
Markets Daniel Marsh

Rolls-Royce Surges on Nuclear Deal, Buyback & Dividend Focus

Rolls-Royce Holdings stock gained 4.8% Friday, buoyed by a UK small modular reactor contract and broader defense sector strength. The company's shares go ex-dividend April 23.

RYCEY
Interactive Brokers Q1 Earnings: Can Momentum Hold Amid Market Highs?
Earnings James Calloway

Interactive Brokers Q1 Earnings: Can Momentum Hold Amid Market Highs?

Interactive Brokers reports first-quarter earnings Tuesday, with analysts forecasting ~60 cents per share. The broker saw strong yearly growth in trading activity and client assets in March, though monthly figures softened.

IBKR SCHW
Oil Markets on Edge as Hormuz Tensions Threaten Supply Flow
Commodities Rebecca Torres

Oil Markets on Edge as Hormuz Tensions Threaten Supply Flow

Crude oil futures fell sharply as shipping through the critical Strait of Hormuz faced renewed disruptions, with Brent closing at $90.38 and WTI at $83.85. The IEA reported a significant March supply drop.

XOM CVX XLE USO
Google in Talks with Marvell for Custom AI Chips, Boosting Custom Silicon Race
Technology Sarah Chen

Google in Talks with Marvell for Custom AI Chips, Boosting Custom Silicon Race

Alphabet's Google is in discussions with Marvell Technology to design two new AI chips, according to a report. The move would deepen Marvell's role in the custom chip market for cloud giants.

GOOG GOOGL MRVL AVGO NVDA META
AST SpaceMobile Satellite Launch Anomaly Threatens 2026 Network Timeline
Technology Sarah Chen

AST SpaceMobile Satellite Launch Anomaly Threatens 2026 Network Timeline

AST SpaceMobile's critical BlueBird 7 satellite experienced an orbital anomaly following its launch on Blue Origin's New Glenn rocket, creating uncertainty for the company's planned 2026 commercial service deployment.

ASTS
Blue Origin Achieves Key Reusability Milestone with New Glenn Booster Landing
Technology Sarah Chen

Blue Origin Achieves Key Reusability Milestone with New Glenn Booster Landing

Blue Origin recovered a previously flown New Glenn rocket booster following the launch of AST SpaceMobile's BlueBird 7 satellite, marking its first successful reuse mission and advancing competition in the reusable launch sector.

AMZN SPCE
Social Security COLA Forecast Rises on Energy-Driven Inflation
Economy Daniel Marsh

Social Security COLA Forecast Rises on Energy-Driven Inflation

Preliminary projections for the 2027 Social Security cost-of-living adjustment have increased to a range of 2.8% to 3.2%, following a March inflation report showing a 3.3% annual rise in the CPI-W index, largely fueled by energy costs.

USO
Chevron Shares Slide Amid Oil Price Volatility and Strait of Hormuz Tensions
Commodities Rebecca Torres

Chevron Shares Slide Amid Oil Price Volatility and Strait of Hormuz Tensions

Chevron shares declined Friday as oil prices dropped sharply following a temporary reopening of the Strait of Hormuz. However, renewed tensions and reported gunfire at the vital waterway have reignited supply concerns ahead of Monday's trading session.

CVX XOM XLE USO BP SHEL
Algoma Central, GSK, AT&T Lead Market Moves as Bitcoin Pool Mines Second Block
Markets Daniel Marsh

Algoma Central, GSK, AT&T Lead Market Moves as Bitcoin Pool Mines Second Block

Algoma Central surpassed its 50-day moving average after a dividend hike, while GSK shares surged to a multi-decade peak. AT&T's valuation suggests significant upside, and a novel bitcoin mining pool confirmed its hybrid model.

ALC GSK T MTB PPA XAR GOOG SHOP TSM
Definium's Psychedelic Drug DT120 Gains Analyst Backing Ahead of Key 2026 Data
Analysis Daniel Marsh

Definium's Psychedelic Drug DT120 Gains Analyst Backing Ahead of Key 2026 Data

Definium Therapeutics advanced after Stifel and Piper Sandler issued Buy ratings, spotlighting its LSD-based drug DT120 in late-stage trials for anxiety and depression. The company will host an investor day on April 22 to discuss upcoming Phase 3 data expected through 2026.

JNJ
AEVEX Soars 35% in NYSE Debut, Raising $320M in Defense-Tech IPO
IPO Michael Okonkwo

AEVEX Soars 35% in NYSE Debut, Raising $320M in Defense-Tech IPO

AEVEX shares closed at $26.93 on their first trading day, a 35% jump from the $20 IPO price. The defense-tech company raised $320 million as it capitalizes on heightened military demand for unmanned systems.

KTOS AVAV